Nutritional Assessment in Patient of Mucopolysaccharide "
Nutritional Assessment of Patient of Mucopolysaccharide
1 other identifier
interventional
40
0 countries
N/A
Brief Summary
" Nutritional assessment in patients of Mucopolysaccharide "
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Aug 2025
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 9, 2025
CompletedStudy Start
First participant enrolled
August 16, 2025
CompletedFirst Posted
Study publicly available on registry
August 22, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 30, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
August 30, 2026
August 22, 2025
August 1, 2025
12 months
August 9, 2025
August 15, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Prevalence of malnutrition among patients with mucopolysaccharidosis
The percentage of patients diagnosed with malnutrition, as determined using the World Health Organization (WHO) growth standards. Malnutrition will be defined based on weight-for-age, height-for-age, and weight-for-height Z-scores below -2 standard deviations. Data will be collected at baseline and expressed as a percentage of the study population.
1 year
severity of malnutrition among patients with mucopolysaccharidosisby WHO growth standards Z-scores (weight-for-age, height-for-age, weight-for-height)
Severity of malnutrition will be assessed using the Gomez classification based on weight-for-age percentage of the median for the reference population. Categories include: mild (75-89%), moderate (60-74%), and severe (\<60%). Data will be expressed as the proportion of patients in each severity category at baseline
At baseline (upon enrollment)
Prevalence and severity of malnutrition among patients with mucopolysaccharidosis
The proportion of patients diagnosed with mucopolysaccharidosis (MPS) who present with any degree of malnutrition, categorized as mild, moderate, or severe according to WHO growth standards. Severity will be determined using anthropometric indices (weight-for-age, height-for-age, BMI-for-age z-scores, and mid-upper arm circumference) and compared across disease subtypes and age groups.
At baseline (upon enrollment)
Study Arms (1)
Nutritional Assessment in Children with Mucopolysaccharidosis
OTHERParticipants diagnosed with Mucopolysaccharidosis will undergo detailed nutritional assessment, including anthropometric measurements, skinfold thickness evaluation, and bioelectrical impedance analysis. Dietary intake will be recorded, and relevant biochemical parameters will be measured.
Interventions
Participants will undergo a comprehensive nutritional assessment, including anthropometric measurements (weight, height, BMI, skinfold thickness), dietary intake evaluation through 24-hour recall, and bioelectrical impedance analysis to assess body composition. Relevant biochemical parameters will also be measured to evaluate nutritional status
Eligibility Criteria
You may qualify if:
- Age between 1 and 18 years
- Stable clinical condition at time of enrollment
- Informed consent obtained from parent/guardian, and assent from child when applicable -
You may not qualify if:
- Acute illness or hospitalization within the last 2 weeks prior to assessment
- Patients who received nutritional supplementation or dietary intervention within 3 months prior to enrollment that could affect baseline nutritional assessment
- Refusal or inability to comply with study assessments
Contact the study team to confirm eligibility.
Sponsors & Collaborators
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DIAGNOSTIC
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator,
Study Record Dates
First Submitted
August 9, 2025
First Posted
August 22, 2025
Study Start
August 16, 2025
Primary Completion (Estimated)
July 30, 2026
Study Completion (Estimated)
August 30, 2026
Last Updated
August 22, 2025
Record last verified: 2025-08